IPO registrations (S-1, F-1) · Registrants
Ampio Pharmaceuticals, Inc.
- SEC CIK
- 1411906 · filings on EDGAR ↗
- Former names
- Chay Enterprises, Inc. (2007–2010)
- Registration
- Form S-1, first filed 2010-11-12, last 2023-12-21; 3 initial registrations, 1 amendment
- Outcome
- Declared effective 2011-02-25; withdrawal requested 2011-01-07
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 9800 MOUNT PYRAMID COURT, SUITE 400, Englewood, CO 80112
- EIN
- 26-0179592
- EDGAR entity type
- operating
- Insiders and CEO pay
- Ampio Pharmaceuticals, Inc. on the corporate pages
On this site
- Lobbying client: AMPIO PHARMACEUTICALS, INC. Fuzzy (name and state)
- SEC filer: Ampio Pharmaceuticals, Inc. EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-11-12 | S-1 | S-1 (registration) | Ampio Pharmaceuticals, Inc. | 0001193125-10-259087 ↗ |
| 2011-01-07 | RW | RW (withdrawal request) | Ampio Pharmaceuticals, Inc. | 0001193125-11-003036 ↗ |
| 2011-02-25 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-11-000546 ↗ |
| 2011-04-19 | S-1 | S-1 (registration) | Ampio Pharmaceuticals, Inc. | 0001193125-11-102082 ↗ |
| 2011-05-23 | S-1/A | S-1/A (amendment) | Ampio Pharmaceuticals, Inc. | 0001193125-11-147992 ↗ |
| 2011-06-07 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-11-001760 ↗ |
| 2011-10-28 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-11-003094 ↗ |
| 2014-01-22 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-14-000177 ↗ |
| 2017-04-20 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-17-000888 ↗ |
| 2020-05-06 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-20-001064 ↗ |
| 2023-09-27 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-23-002899 ↗ |
| 2023-12-21 | S-1 | S-1 (registration) | Ampio Pharmaceuticals, Inc. | 0001558370-23-019958 ↗ |
| 2024-02-28 | RW | RW (withdrawal request) | Ampio Pharmaceuticals, Inc. | 0001558370-24-001977 ↗ |
| 2024-03-04 | EFFECT | EFFECT (declared effective) | Ampio Pharmaceuticals, Inc. | 9999999995-24-000592 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-05-23 | S-1/A | registration statement | 6,762,609 | - | Nasdaq AMPE | 0 | primary document; shares headline | document ↗ | ||
| 2023-12-21 | S-1 | registration statement | - | - | NYSE American AMPE | 0 | primary document; no terms found | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bar-Or David | Director; Director,Officer | Chief Scientific Officer | 19 | 2011–2022 | |
| CLIFT VAUGHAN LENNOX | Officer | Chief Regulatory Affairs | 6 | 2011–2015 | |
| COELHO PHILIP H | Director | 33 | 2011–2022 | ||
| Giles Richard B | Director | 27 | 2011–2022 | ||
| MACALUSO MICHAEL | Director; Director,Officer; Officer | CEO; Chief Executive Officer | 15 | 2011–2022 | |
| McGregor Mark D | Officer | Chief Financial Officer | 3 | 2011–2013 | |
| Stevens David R | Director | 23 | 2011–2023 | ||
| Wingerter Donald B Jr | Director,Officer | Chief Executive Officer | 1 | 2011 | |
| Disbrow Joshua R. | Officer | Chief Operating Officer | 3 | 2013 | |
| Gould Gregory A | Officer | Chief Financial Officer | 3 | 2014–2016 | |
| Chilcott, III Thomas E. | Officer | Chief Financial Officer | 4 | 2017–2018 | |
| Cherevka Holli | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER; PRESIDENT AND COO | 9 | 2017–2022 | |
| STOKELY DAN | Officer | CFO | 12 | 2019–2022 | |
| BUCHI J KEVIN | Director | 7 | 2021–2023 | ||
| MARTINO MICHAEL A | Director; Director,Officer | CEO; INTERIM CHAIRMAN AND CEO | 5 | 2021–2023 | |
| JOBES ELIZABETH VARKI | Director | 2 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Lobbying client | AMPIO PHARMACEUTICALS, INC. | CO | Federal lobbying (LDA) | name and state |
| Patent assignee | Ampio Pharmaceuticals, Inc. | CO | Patents (USPTO) | name and state |
| SEC filer | Ampio Pharmaceuticals, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Ampio Pharmaceuticals, Inc. | CO | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CO first:
- ALLOS THERAPEUTICS INC CO
- ARRAY BIOPHARMA INC CO
- MYOGEN INC CO
- PHARMION CORP CO
- GLOBEIMMUNE INC CO
- Statera Biopharma, Inc. CO
- AYTU BIOPHARMA, INC CO
- MusclePharm Corp CO
- United Cannabis Corp CO
- Clovis Oncology, Inc. CO
In other datasets, the same topic (Health) in CO:
- Nonprofit: 3 4 FIGHTING PARKINSONS (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health